Because endogenous thromboxane A2 (TXA2) potentiates the tubuloglomerular feedback response (TGF), we studied the mechanism of action of TXA2 by using a stable TXA2/prostaglandin (PG) H2 mimetic, U46,619. Intravenous infusion of U46,619 at 100 ng * kg-' . min-' reduced the GFR and the single-nephron (SN)GFR measured from the distal tubule (macula densa function intact), whereas the SNGFR measured from the proximal tubule (macula densa function interrupted) was not changed consistently. 10-100-fold higher rates of infusion of U46,619 were required to raise blood pressure or femoral vascular resistance. The regulation of glomerular capillary pressure (PGC) by TGF was assessed in anesthetized rats from changes in proximal stop flow pressure (PSF) and/or SNGFR during perfusion of the loop of Henle (LH) with artificial tubular fluid (ATF). Orthograde loop perfusion and retrograde perfusion of U46,619 into the macula densa segment reduced PSF. Responses to luminal U46,619 were blunted by a TXA2-PGH2 receptor antagonist. Orthograde loop perfusions with luminal U46,619 increased net Cl absorption, whereas coperfusion with furosemide (10-i M) blunted the response to U46,619 by 68%. These data indicated that the luminal U46,619 might increase the signal for TGF activation by increasing Cl reabsorption in macula densa cells. However, since 80±4% of IHIU-46,619 perfused via the LH was reabsorbed, peritubular capillaries (PTC) were perfused with U-46,619 to test additional extra-luminal actions. PTC perfusion with U-46,619 again increased TGF by reducing PSF selectively only while macula densa function was intact during perfusion of the LH with ATF. Conclusions: (a) TGF is potentiated by U46,619 given systemically, via the lumen of the LH by orthograde or retrograde perfusions or via the PTC; (b) at the lower doses tested, reduction of PGC and SNGFR by U46,619 depends on tubular fluid delivery and reabsorption by the macula densa; (c) potentiation ofTGF by U46,619 entails preglomerular vasoconstriction which may be elicited in part by an increased signal due to increased net chloride reabsorption in the LH and presumably macula densa cells and by an increased Parts of this report were presented in abstract form
Introduction
Tubuloglomerular feedback (TGF)l is a vasoconstrictive re- sponse that reduces the glomerular capillary pressure (PGC) and the single-nephron glomerular filtration rate (SNGFR) and limits NaCl excretion. It depends upon delivery and reabsorption ofNaCl in the macula densa segment ofthe loop ofHenle (LH) (1, 2) . Adenosine (3) and angiotensin 11 (4, 5) have been implicated in the preglomerular vasoconstriction. Using a wholekidney model of TGF entailing intrarenal infusion of hypertonic NaCI, we demonstrated increased release of the thromboxane A2 (TXA2) metabolite TXB2 into renal lymph and urine (6) and blunting ofthe pre-and postglomerular vasoconstriction by a TXA2 synthesis inhibitor (7) . Thereafter, in single-nephron studies, inhibition of endogenous TXA2 synthesis or TXA2 prostaglandin (PG) H2 receptors was found to blunt the fall in SNGFR and PGc during orthograde perfusion ofthe LH (8) by an angiotensin-independent mechanism (5). The aim of the present study was to investigate the mechanisms whereby TXA2 potentiates TGF-induced changes in PGc using a stable TXA2/PGH2 mimetic U-46,619 (9) .
The hierarchy of responses to intravenous U-46,619 was assessed from dose-response relationships for TGF-induced changes in PGc, SNGFR, renal and femoral hemodynamics, and blood pressure (BP). The role of TXA2/PGH2 receptors was assessed using the specific, competitive receptor antagonist, SQ-29,548 (10) . Because TXB2 has been detected recently in proximal tubule fluid (11, 12) , we tested the effects of U-46,619 delivered via the lumen ofthe perfused loop ofHenle (LH) on the TGF response. The role ofthe macula densa in the response to U-46,619 was assessed by retrograde infusion of U-46,619 from the distal tubule into the macula densa segment and from a comparison of the effects of intravenous U-46,619 on SNGFR measured from the proximal and distal tubules.
During proximal tubule fluid collection, the delivery oftubular fluid to the macula densa segment is interrupted while during distal tubule collection it is intact (13) . Recently macula densa cells have been shown to resemble thick ascending LH cells in possessing a furosemide-sensitive apical Na/K/2Cl cotransport step ( 14) . Therefore, further studies were undertaken to assess the effect of U-46, 6 19 on the signal generated by reabsorption of NaCl by the macula densa cells, or the response ofthe arteriole to this signal. This was studied from the effects of luminal perfusion of the Na/K/2C1 cotransport inhibitor, furosemide, on TGF responses to graded doses of luminal U-46,619 and from measurement of net Cl reabsorption (JQ) in the LH during perfusion with U-46,619. To determine whether U-46,619 could engage TGF via an extraluminal action, the drug was infused directly into the peritubular capillaries while TGF was assessed from changes in PSF during graded perfusion of the LH of the target nephron with artificial tubular fluid.
Methods
Animal preparation. Male Sprague-Dawley rats (211-254 g) were maintained on rat chow (rodent laboratory Chow 5001; Ralston Purina Co., St. Louis, MO) and surgically prepared for in vivo micropuncture as previously described in detail (8) . Albumin (3 g-dl-'; Sigma Chemical Co., St. Louis, MO) was dissolved in 0.15 M NaCl and infused throughout at 0.5 ml* 100 g body weight-' * h-' after a priming dose of 0.5 ml to maintain a euvolemic state.
[3H]inulin (0.1 Ci * kg-' * h-') and ['4C]paraaminohippurate (0.05 tiCi -kg-' -h-', both supplied by New England Nuclear, Boston, MA) were added to this infusion to measure GFR and renal plasma flow (RPF), respectively. [3H]Inulin was infused at adose of0.5 ,Ci * kg-* h-1 for measurement ofSNGFR.
Renal extraction of PAH was not assessed; previous studies had shown that alteration in endogenous TXA2 generation did not alter renal paraaminohippurate extraction in the rat (7) . Renal vascular resistance (RVR) was calculated from mean BP (MBP) factored by renal blood flow (RBF).
Individual nephrons were identified by insertion of a localizing pipette (4-6 um, o.d.) and injection of a small volume (10-20 nl) of artificial tubular fluid (ATF), which had a composition similar to endproximal tubule fluid (5) and was stained with fast-green (1% F, D and C, Sigma Chemical Co.). The last loop of the proximal tubule was punctured with a perfusion pipette (7-10 ,m, o.d.) connected to a variable nanoliter perfusion pump (World Precision Instruments, Inc., New Haven, CT). An immobile wax block was placed in the proximal tubule upstream from the perfusion pipette using a hydraulic syringe (Trent Wells, San Diego, CA). A pressure pipette (1-2 .m, o.d.) connected to a servonull pressure measuring device (IPM, Inc., La Jolla, CA) was inserted into the proximal tubule upstream from the wax block to measure the proximal stop flow pressure (PSF). PSF defines the net filtering pressure at the glomerulus; in the absence of a change in plasma oncotic pressure, PSF is proportional to PGC. The changes in PSF during graded alterations in the rate of flow of ATF into the LH from 0 to 40 nl* min-' were used to characterize the TGF response.
There is normally a sigmoidal relationship between PSF and LH perfusion. The set point for the TGF response was taken as the value ofPSF during zero LH perfusion. The overall response was taken as the change in PSF between 0 and 40 nl* min-' of LH perfusion. The turning point was assessed using a curve-fitting program as the rate of LH perfusion corresponding to a 50% change in PSF. In some studies, the TGF response was assessed from changes in SNGFR; for one set of studies, timed collections of proximal tubule fluid were made during perfusion of the LH with ATF at 0 and 40 nl* min'. For another set, free-flow micropuncture samples were drawn from the proximal and distal tubules upstream from a mobile oil droplet. Tubular fluid volumes were measured in a calibrated, constant-bore micropipette and tubular fluid flow rate (TFv) was calculated. SNGFR was taken as the product of TFv and the tubular fluid/plasma ratio for 3H activity.
After completion of surgery, there was a 30-min equilibration period. For the first series, this was followed by a basal period of 90 min (period 1) during which clearance and micropuncture measurements were made. Thereafter, test solutions or vehicle were infused and, after 5 min, there was an experimental period of 90 min (period 2) when clearance and micropuncture measurements were repeated. Blood was sampled at the midpoints. This protocol followed exactly previous series (5, 8) where it was shown that, if no drugs were given during period 2, there were no changes between periods 1 and 2 in MBP, GFR, RPF, urine flow rate (UV), renal excretion of sodium (UNaV), potassium (UKV), chloride (UaV), prostacyclin (PGI2) metabolite (U6kPGFhrV), or TXA2 metabolite (UTXB2V). Moreover, TGF responses, whether assessed from changes in PSF or SNGFR also remained stable.
Protocols. (10-6 M) .
The aim of the third protocol was to test the hypothesis that the effect of luminal U-46,619 on TGF was mediated by specific TXA2/ PGH2 receptors, using the TXA2/PGH2 receptor antagonist SQ-29,548 (10) . TGF was assessed from measurements of SNGFR during perfusion of the LH with ATF at 0 and 40 nl* min-' (order randomized), as described above. The effects of perfusion of the LH with U-46,619 (10-6 M) (2, 13, 14) . Because this could not be measured directly, it was assessed from the effects of luminal furosemide (I0-M) on U-46,6 19-induced changes in PSF; furosemide blocks the entry step for Na/K/2C1 absorption by both thick ascending limb and macula densa cells (14) . In 02 and 5% CO2 as described by Mitchell and Navar (15) . The rate of perfusion used was well below that which led to any apparent back-flux of perfuLsate down the efferent arteriole toward the glomerulus. Moreover, green dye did not appear in tubular fluid but escaped from the capillaries and stained the region surrounding the experimental nephron. Perfusion of some PTCs did not cause greening of the interstitium around the test nephron; these nephrons were not studied further. The TGF response was assessed by increasing the LH perfusion from 0 to 40 nl * min-' and back to 0. It is not possible to withdraw the efferent arteriolar micropipette without inducing significant bleeding. Therefore, the TGF responses were assessed during PCT perfusion and compared to those obtained with the micropipette in place, but the perfusion not engaged. For the first control group (n = 6), the PTCs were perfused with APF + vehicle while for the second experiments group (n = 7) they were perfused with APF + U-46,619 (10-6 M).
Chemical methods. Samples of plasma, urine and tubular fluid were assessed for radioactivity in a liquid scintillation counter (Beckman Instruments, Inc., Palo Alto, CA). Na and K concentrations were measured in a flame photometer ( were assessed using an analysis of variance (ANOVA); post-hoc Student's t tests were applied thereafter to parameters or dosages which showed significant effects. Values were taken as statistically significant at P < 0.05.
Results
The dose-response relationships for changes in GFR, RVR, FVR, and MBP during i.v. infusion of U46, 6 19, compared to its vehicle, are shown in Fig. 1 . It is apparent that RVR and GFR were much more sensitive and responsive to U-46,619 than were either FVR or BP. Further data on the dose-response relationships are presented in Table I . The set point for the TGF response (i.e., the values of PSF or SNGFR in the absence of LH perfusion) and the turning point were unaffected by intravenous U-46,619 up to and including 100 ng -kg' -min-'. In contrast, the maximal PSF response (i.e., the change in PSF during changes in the perfusion of the LH with ATF between 0 and 40 nl * min') was increased by 90% during intravenous infusion of U-46,619 at a dose of 10 ng. kg-' -min'. However, neither the GFR nor the RPF was For protocol 3, TGF was assessed in seven nephrons from changes in SNGFR during perfusion of the LH at 0 and 40 nl -min-' with ATF. The SNGFR in the absence of perfusion ofthe LH was 34.6±1.5 nl* min-'. During perfusion ofthe LH at 40 nl * min' with ATF + vehicle, the SNGFR was reduced (P < 0.01) to 23.0±2.3 nl-min-'. The SNGFR was reduced further (P < 0.001) with U-46,619 (10-6 M) 17.2±2.6 nl * min'). The To examine the effects of luminal U-46,619 on macula densa mediated changes in PSF, without potentially confounding effects of alteration in NaCl transport in the LH upstream from this segment, TGF-induced changes in PSF were analyzed during retrograde perfusion ofthe macula densa segment from the early distal tubule at 10 nl -min' in four nephrons For the seventh protocol, PTC perfusion with APF alone at 15 nl min-' did not modify the TGF response. Additional studies contrasted the effects ofPTC perfusions at 15 nl -min-' with U-46,619 (10-6 M) added to APF compared to sham perfusions. The PSF was measured in adjacent nephrons during zero perfusion of the LH and during perfusion with ATF at 40 nl-min-'. Perfusion with U-46,619 in APF consistently reduced PSF during perfusion of the LH with ATF at 40 nl -min' yet had no effect when the LH was not perfused (Fig. 7) .
Because [3H]U-46,619 was reabsorbed from the LH, the possibility was considered that U-46,619 perfused into the PTC gained access to the LH perfusion. Accordingly, [3H]U-46,619 (40 cpm-nu') was added to APF and perfused into the PTC during luminal perfusion of the adjacent LH with ATF at 40 nl-min'. The LH perfusate was collected over 3-5 min from the early distal tubule and analyzed for 3H activity. In three studies, no measurable 3H activity was detected. Evidence for involvement ofendogenous TXA2 in the modulation of the TGF response was derived from experiments which showed that drugs which inhibit TXA2 synthase or TXA2/PGH2 receptors blunted the TGF response by 40-60% (5, 8) . However, Franco et al. (17) found that local perfusion of the LH with drugs that block TXA2 synthesis or receptors did not alter the TGF responses. These differences may be explained because endogenous TXA2 was not produced in the perfused LH since this is not a major site of TXA2 synthesis (18 Potentiation ofTGF by U-46,619 is probably not related to renin release inasmuch intravenous infusion of U-46,619 into anesthetized rats reduced plasma renin activity (19) . Moreover, even at much higher doses, renal hemodynamic responses to TXA2/PGH2 mimetics are unaffected by angiotensin antagonists (20) . Indeed, we found that endogenous release of TXA2 and angiotensin II potentiated TGF by independent means (5) .
An apparent paradox was the finding that i.v. infusion of U46,619 potentiated TGF-induced changes in the maximal PSF response at a dose below that required to reduce wholekidney GFR or RPF (Table I) . A likely explanation is that maximal PSF responses were tested by increasing the rate of LH perfusion to 40 nl -min-', which greatly exceeds the normal end-proximal flow rate of 10-20 nl * min'. Indeed, examination of Figure 2 shows that intravenous U-46,619 potentiated TGF at these lower, more physiologically relevant levels of LH perfusion only at doses which corresponded to those which did lower GFR and RPF. The present results raise the possibility that the extreme sensitivity and responsiveness of the renal circulation to U-46,619 may depend upon its engagement ofthe unique renal mechanism ofTGF. Thus, with macula densa cell function intact, infusion of U-46,619 at 10 ng -kg-' e min' did not alter either SNGFR measured from the distal tubule or whole-kidney GFR (Table I) . However, infusion ofU-46,619 at 100 ng -kg`-min' led to a 38% reduction in distal SNGFR and a 32% reduction in whole-kidney GFR. This vasoconstrictive action to these low doses ofU-46,619 was apparently mediated by the macula densa since there were no consistent changes in either PSF or SNGFR in the absence of perfusion of the macula densa segment. The vasoconstriction was highly selective since a 10-100-fold higher rate ofinfusion of U-46,619 was required to increase FVR or BP. Further evidence for macula densa-mediated renal vasoconstriction by TXA2 derives from our previous finding that a TXA2 synthase inhibitor increases RBF and GFR and reduces pre-and postglomerular vascular resistances only during hyperchloremia (7) which increases macula densa Cl delivery and activates TGF (13) .
We observed previously that, providing renal perfusion pressure is controlled, drugs which inhibit TXA2 synthesis or receptors blunt the TGF response only during high rates ofLH perfusion (5) . This suggests that TXA2 itself may interact with TGF either by augmenting the signal from the macula densa or the afferent arteriolor vasoconstrictor response to this signal. The signal has been related to the reabsorption ofsolutes, notably Cl, in the macula densa segment (13, 14, 21) . This selectivity ofaction ofTXA2 was confirmed in the present series where the effects of U-46,619 in the lower dose ranges on PSF or SNGFR, whether infused systemically or via the PTC or LH were seen only when macula densa cell function was intact.
The present studies provide some support for the hypothesis that one component ofthe action ofU-46,619 on TGF is due to an augmentation ofthe signal at the macula densa since furosemide, which severely blunted loop Cl reabsorption, blunted the Thromboxane Mimetic and Tubuloglomerular Feedback 1863 response to low doses ofU-46,6 19 perfused via the LH. Recent evidence indicates the macula densa cells also contain a luminal, furosemide-sensitive Na,K,2CI cotransporter similar to that described in the thick ascending limb of Henle cells (14) . The evidence that luminal U-46,619 enhanced loop J0 suggests that U-46,619 can promote TGF by augmenting Cl reabsorption by the macula densa cells. Previous studies had shown that loop Cl absorption and TGF responses increase in parallel during perfusion of the LH between 10 and 30 nl* min-' (22) . However, at higher rates of C1 delivery and reabsorption, a ceiling is approached beyond which TGF responses are not augmented further (23) . Our results showed that U-46,619 reduced PSF across a broad range of Cl deliveries (Fig. 6 ). The unique relationship between PSF and J0 is consistent with a predominant role for Cl transport in the regulation of TGF by U-46,619. However, the enhancement of Jc0 by luminal U-46,6 19 reduced the [Cl] of early distal tubule fluid (Fig. 5) . Thus, TGF was studied during retrograde perfusion from the early distal tubule to obviate any confounding effects due to alterations in tubular transport upstream from the macula densa. When given more directly near the macula densa, luminal U-46,619 again reduced PSF. This suggests that U-46,619 can alter the signal sensing mechanism at the macula densa. However, if the sole effect of U-46,6 19 was to augment macula densa cell Cl transport, one might anticipate that the drug would augment the PSF response to low rates of LH perfusion but would have no further effect when given during perfusion ofthe LH with ATF at 40 nl * min-I when Cl delivery and reabsorption are maximally effective in stimulating TGF. The data for both intravenous and luminal delivery of U-46,619 (Figs. 2 and 3) suggest that the drug augments PSF during both low and maximal rates ofLH perfusion with ATF. This suggests that U-46,619 may also increase the sensitivity of the TGF response. This may be analagous to the recent clarification of the action of angiotensin II on the renal afferent arteriole which requires the presence of a signal generated by the macula densa, perhaps related to adenosine release (24). Furthermore, very high doses of this lipid soluble drug U-46,6 19 may diffuse from the tubular lumen and vasoconstrict the afferent arteriole independent of macula densa cell function. This is suggested by the finding that coperfusion with furosemide, to block macula densa cell reabsorption, did not significantly attenuate the rise in PSF induced by luminal U-46,619 at the highest dose tested.
The mechanism whereby U-46,619 stimulated Cl transport in the LH was not established in these studies. U-46,619 promotes net Cl secretion in the stomach and ileum (25) while infusions of a TXA2 synthase inhibitor can increase renal Cl excretion (8) . Studies in isolated tubules from mouse (26) and rabbit (27) (28) . Juxtaglomerular cells contain a major calciumactivated chloride conductance (14, 29 where it could interact with a basolateral Cl channel. Indeed, even when given directly into the interstitium by PTC perfusion, U-46,619 did not alter PGC unless macula densa function was intact by simultaneous perfusion of the LH with ATF. Therefore, we conclude that one mechanism whereby U-46,619 reduces PGC entails an enhanced generation of the signal that initiates TGF responses at the macula densa cells.
These studies were undertaken with U-46,619 which, although acting on the same receptor at TXA2, is very lipid soluble and more stable than TXA2, which has a half-life of only some 30 s. The release of TXB2 into urine and renal lymph is increased in a whole-kidney model of TGF (6) whereas TXA2 synthesis inhibitors reverse the pre-and postglomerular vasoconstriction in this model (7) . These observations in the whole animal concur with the more discreet perfusions of the LH of single nephrons (5, 8) and implicate TXA2 in the complex events that relate the tone of the renal resistance vessels to the rate of delivery and reabsorption of NaCl in the LH and macula densa.
